Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia

• Status: Completed
• Trial end date: 2006-07-01

Summary

To determine the efficacy and safety of micafungin (FK463) versus fluconazole (Diflucan) in treating patients with invasive candidiasis or candidaemia

• Phase: Phase 3

Details

• Lead Sponsor: Astellas Pharma Inc
• Collaborator: Astellas Pharma Taiwan, Inc.
• Treatments: Echinocandins; Fluconazole; Micafungin